ctrl K

Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.77

0.03 (4.41%)

At close: Aug 15, 2025, 3:54 PM

0.76

-1.28%

After-hours: Aug 15, 2025, 04:07 PM EDT

Virax Biolabs Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4.23M	3.59M	9.35M	21.76K	17.62K
Short-Term Investments	n/a	77.32K	49.26K	6K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	54.5K
Other Long-Term Assets	n/a	-49.77K	-178.4K	n/a	n/a
Receivables	30.65K	217.84K	n/a	n/a	928.00
Inventory	94.67K	60.38K	24.09K	20.95K	21.07K
Other Current Assets	n/a	77.32K	n/a	n/a	n/a
Total Current Assets	4.89M	4.38M	9.63M	48.71K	39.62K
Property-Plant & Equipment	1.53M	1.1M	n/a	n/a	n/a
Goodwill & Intangibles	n/a	49.77K	178.4K	n/a	n/a
Total Long-Term Assets	1.53M	1.1M	178.4K	n/a	54.5K
Total Assets	6.43M	5.48M	9.81M	48.71K	94.12K
Account Payables	56.09K	45.63K	159.91K	846.47K	217.15K
Deferred Revenue	n/a	n/a	38.25K	-0.00	n/a
Short-Term Debt	32.47K	n/a	146.25K	n/a	n/a
Other Current Liabilities	60.48K	63.12K	140.29K	3.76K	192K
Total Current Liabilities	673.21K	168.85K	908.4K	1.25M	871.43K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	291.54K	176.34K	n/a	n/a	n/a
Total Liabilities	964.75K	345.19K	908.4K	1.25M	871.43K
Total Debt	377K	224.3K	146.25K	3.76K	179.48K
Common Stock	4.34K	2.57K	1.56K	999.00	265.00
Retained Earnings	-24.59M	-18.53M	-11.79M	-6.34M	-4.63M
Comprehensive Income	30.28M	23.89M	20.92M	5.36M	4.03M
Shareholders Equity	5.7M	5.37M	9.13M	-974.58K	-596.18K
Total Investments	n/a	77.32K	49.26K	6K	54.5K